Skip to content

EX-PO Trial : Evaluation of the Occlusion Pressure (PO.1) in Extubation Failure

EX-PO Trial : Evaluation of the Occlusion Pressure (PO.1) in Extubation Failure

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04654273
Enrollment
152
Registered
2020-12-04
Start date
2020-11-30
Completion date
2022-01-31
Last updated
2021-07-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Respiratory Failure

Brief summary

Measuring bedside occlusion pressure in neurosurgical or surgical critically ill patients could tell us about the patient's respiratory drive, and therefore, tell us whether or not extubation will be successful.

Interventions

None listed

Sponsors

Poitiers University Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum

Inclusion criteria

* Age ≥ 18 years old, * Hospitalized in surgical or neurosurgical intensive care units * Patients under mechanical ventilation for more than 48 hours, * Meeting the criteria for severability (spontaneous ventilation test), * Free subject, without tutorship or curatorship or subordination, * Patients benefiting from a Social Security scheme or benefiting through the intermediary of a third party, * No objection given by the patient and / or relative after clear and fair information about the study.

Exclusion criteria

* Tracheostomized patients, * Persons benefiting from enhanced protection, namely minors, persons deprived of their liberty by a judicial or administrative decision, persons staying in a health or social establishment, adults under legal protection, * Pregnant and / or lactating women.

Design outcomes

Primary

MeasureTime frame
Number of re-intubations after extubation7 days

Countries

France

Contacts

Primary ContactDamien MARIE, Dr
damien.marie@chu-poitiers.fr05.49.44.15.65

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026